309 related articles for article (PubMed ID: 19486017)
1. Macroprolactinaemia: prevalence and aetiologies in a large group of hospital workers.
Hattori N; Ishihara T; Saiki Y
Clin Endocrinol (Oxf); 2009 Nov; 71(5):702-8. PubMed ID: 19486017
[TBL] [Abstract][Full Text] [Related]
2. Macroprolactinaemia in patients with hyperprolactinaemia: composition of macroprolactin and stability during long-term follow-up.
Hattori N; Ishihara T; Saiki Y; Shimatsu A
Clin Endocrinol (Oxf); 2010 Dec; 73(6):792-7. PubMed ID: 20874771
[TBL] [Abstract][Full Text] [Related]
3. Should macroprolactin be measured in all hyperprolactinaemic sera?
McKenna TJ
Clin Endocrinol (Oxf); 2009 Oct; 71(4):466-9. PubMed ID: 19320649
[TBL] [Abstract][Full Text] [Related]
4. Macroprolactin; high molecular mass forms of circulating prolactin.
Fahie-Wilson MN; John R; Ellis AR
Ann Clin Biochem; 2005 May; 42(Pt 3):175-92. PubMed ID: 15949152
[TBL] [Abstract][Full Text] [Related]
5. Determination of prolactin: the macroprolactin problem.
Fahie-Wilson M; Smith TP
Best Pract Res Clin Endocrinol Metab; 2013 Oct; 27(5):725-42. PubMed ID: 24094642
[TBL] [Abstract][Full Text] [Related]
6. The natural history of macroprolactinaemia.
Hattori N; Adachi T; Ishihara T; Shimatsu A
Eur J Endocrinol; 2012 Apr; 166(4):625-9. PubMed ID: 22247016
[TBL] [Abstract][Full Text] [Related]
7. [Macroprolactinaemia].
Kostrzak A; Meczekalski B
Pol Merkur Lekarski; 2010 Jul; 29(169):47-9. PubMed ID: 20712249
[TBL] [Abstract][Full Text] [Related]
8. Screening for macroprolactinaemia and pituitary imaging studies.
Hauache OM; Rocha AJ; Maia AC; Maciel RM; Vieira JG
Clin Endocrinol (Oxf); 2002 Sep; 57(3):327-31. PubMed ID: 12201824
[TBL] [Abstract][Full Text] [Related]
9. Macroprolactin(s): composition and reactivity in immunoassays and laboratory interpretation of results of an unusual patient serum.
Ellis AR; Fahie-Wilson M; Axcell M; Sands K; Hill RP
Ann Clin Biochem; 2006 Jan; 43(Pt 1):57-62. PubMed ID: 16390610
[TBL] [Abstract][Full Text] [Related]
10. Characterization of macroprolactin and assessment of markers of autoimmunity in macroprolactinaemic patients.
Kavanagh-Wright L; Smith TP; Gibney J; McKenna TJ
Clin Endocrinol (Oxf); 2009 Apr; 70(4):599-605. PubMed ID: 18771565
[TBL] [Abstract][Full Text] [Related]
11. Clinical and radiological features of patients with macroprolactinaemia.
Strachan MW; Teoh WL; Don-Wauchope AC; Seth J; Stoddart M; Beckett GJ
Clin Endocrinol (Oxf); 2003 Sep; 59(3):339-46. PubMed ID: 12919157
[TBL] [Abstract][Full Text] [Related]
12. Coexistence of macroprolactinaemia and hyperprolactinaemia in women with oligo-/amenorrhoea is associated with high risk of pituitary adenomas.
Lewandowski KC; Gasior-Perczak D; Kowalska A; Lewinski A
Gynecol Endocrinol; 2014 May; 30(5):385-7. PubMed ID: 24533748
[TBL] [Abstract][Full Text] [Related]
13. Patients with macroprolactinaemia: clinical and radiological features.
Donadio F; Barbieri A; Angioni R; Mantovani G; Beck-Peccoz P; Spada A; Lania AG
Eur J Clin Invest; 2007 Jul; 37(7):552-7. PubMed ID: 17576206
[TBL] [Abstract][Full Text] [Related]
14. Macroprolactin: what is it and what is its importance?
Sadideen H; Swaminathan R
Int J Clin Pract; 2006 Apr; 60(4):457-61. PubMed ID: 16620360
[TBL] [Abstract][Full Text] [Related]
15. Importance of screening for macroprolactin in all hyperprolactinaemic sera.
Jamaluddin FA; Sthaneshwar P; Hussein Z; Othman N; Chan SP
Malays J Pathol; 2013 Jun; 35(1):59-63. PubMed ID: 23817395
[TBL] [Abstract][Full Text] [Related]
16. False-positive polyethylene glycol precipitation tests for macroprolactin due to increased serum globulins.
Ram S; Harris B; Fernando JJ; Gama R; Fahie-Wilson M
Ann Clin Biochem; 2008 May; 45(Pt 3):256-9. PubMed ID: 18482912
[TBL] [Abstract][Full Text] [Related]
17. Importance of macroprolactinemia in hyperprolactinemia.
Kasum M; Pavičić-Baldani D; Stanić P; Orešković S; Sarić JM; Blajić J; Juras J
Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():28-32. PubMed ID: 25461348
[TBL] [Abstract][Full Text] [Related]
18. Anti-prolactin (PRL) autoantibodies suppress PRL bioactivity in patients with macroprolactinaemia.
Hattori N; Nakayama Y; Kitagawa K; Ishihara T; Saiki Y; Inagaki C
Clin Endocrinol (Oxf); 2008 Jan; 68(1):72-6. PubMed ID: 17681026
[TBL] [Abstract][Full Text] [Related]
19. Hyperprolactinaemia does not always mean 'hyperprolactinaemia'!
Gezer A; Atasü T; Hekim C; Stenman UH; Hekim N
Eur J Obstet Gynecol Reprod Biol; 2005 Feb; 118(2):206-8. PubMed ID: 15653204
[TBL] [Abstract][Full Text] [Related]
20. Macroprolactin does not contribute to elevated levels of prolactin in patients on renal replacement therapy.
Yavuz D; Topçu G; Ozener C; Akalin S; Sirikçi O
Clin Endocrinol (Oxf); 2005 Nov; 63(5):520-4. PubMed ID: 16268803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
